129 related articles for article (PubMed ID: 22305512)
1. Stop and go strategy for opioid switching requires flexibility.
Mercadante S
Eur J Cancer; 2012 Apr; 48(6):944-5; author reply 946-7. PubMed ID: 22305512
[No Abstract] [Full Text] [Related]
2. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.
Moksnes K; Kaasa S; Paulsen Ø; Rosland JH; Spigset O; Dale O
Eur J Clin Pharmacol; 2012 Aug; 68(8):1147-56. PubMed ID: 22374345
[TBL] [Abstract][Full Text] [Related]
4. Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone Pharmacokinetics.
Glue P; Cape G; Tunnicliff D; Lockhart M; Lam F; Gray A; Hung N; Hung CT; Harland S; Devane J; Howes J; Weis H; Friedhoff L
J Clin Pharmacol; 2016 Aug; 56(8):960-5. PubMed ID: 26763764
[TBL] [Abstract][Full Text] [Related]
5. [Opioid switch and change of route of administration in cancer patients treated by morphine].
Michenot N; Rostaing S; Baron L; Faure S; Jovenin N; Hubault P; Delorme T; Collin E; Filbet M; Chvetzoff G; Delorme C; Minello C; Magnet M; Ammar D; Krakowski I; Poulain P
Bull Cancer; 2018 Nov; 105(11):1052-1073. PubMed ID: 30274680
[TBL] [Abstract][Full Text] [Related]
6. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.
Narabayashi M; Saijo Y; Takenoshita S; Chida M; Shimoyama N; Miura T; Tani K; Nishimura K; Onozawa Y; Hosokawa T; Kamoto T; Tsushima T;
Jpn J Clin Oncol; 2008 Apr; 38(4):296-304. PubMed ID: 18326541
[TBL] [Abstract][Full Text] [Related]
7. Opioid therapy for chronic painful conditions.
Burgess FW
Med Health R I; 2001 Oct; 84(10):323-6. PubMed ID: 11693049
[No Abstract] [Full Text] [Related]
8. Switching from oxycodone to methadone in advanced cancer patients.
Mercadante S; Ferrera P; Villari P; Adile C; Casuccio A
Support Care Cancer; 2012 Jan; 20(1):191-4. PubMed ID: 21901297
[TBL] [Abstract][Full Text] [Related]
9. Switching to methadone: 'ad libitum' or fixed dose ratio?
Mercadante S
Palliat Med; 2004 Jan; 18(1):71; author reply 72. PubMed ID: 14982211
[No Abstract] [Full Text] [Related]
10. [From ketobemidone to morphine or oxycodone].
Ræder J; Dahl V; Markestad A; Nordbø A; Roaldset AH; Stubhaug A; Søeberg B; Willke A; Aasbø V; Johansen PW
Tidsskr Nor Laegeforen; 2016 Oct; 136(18):1518-1519. PubMed ID: 27731593
[No Abstract] [Full Text] [Related]
11. Inconsistencies in opioid equianalgesic ratios: clinical and research implications.
O'Bryant CL; Linnebur SA; Yamashita TE; Kutner JS
J Pain Palliat Care Pharmacother; 2008; 22(4):282-90. PubMed ID: 21923312
[TBL] [Abstract][Full Text] [Related]
12. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F
J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694
[TBL] [Abstract][Full Text] [Related]
13. Therapy switching in patients receiving long-acting opioids.
Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic treatment of cancer pain.
Bruera E; Fainsinger RL
N Engl J Med; 1997 Mar; 336(13):962-3; author reply 963. PubMed ID: 9072703
[No Abstract] [Full Text] [Related]
15. [Morphine or oxycodone tablets for pain?].
Fredheim OM; Dale O; Kaasa S; Borchgrevink PC
Tidsskr Nor Laegeforen; 2010 Aug; 130(15):1479-81. PubMed ID: 20706310
[TBL] [Abstract][Full Text] [Related]
16. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of pain in cancer with systemically administered opioids].
Enting RH; van der Rijt CC; Wilms EB; Lieverse PJ; de Wit R; Smitt PA
Ned Tijdschr Geneeskd; 2001 May; 145(20):950-4. PubMed ID: 11396259
[TBL] [Abstract][Full Text] [Related]
19. Morphine infusor pump switch to oral methadone.
Santos Suárez J; Del Valle Arnáez G
BMJ Support Palliat Care; 2020 Mar; 10(1):1-3. PubMed ID: 30944123
[TBL] [Abstract][Full Text] [Related]
20. Opioid switch to oral methadone in cancer pain.
Mancini I; Lossignol DA; Body JJ
Curr Opin Oncol; 2000 Jul; 12(4):308-13. PubMed ID: 10888415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
